-
11β-HSD1 Inhibition Reduces Liver Fibrosis
2026-09-17
A 2025 mouse study identifies a mechanistic link between 11β-HSD1 inhibition, reduced intracellular cortisol, Notch pathway suppression, and enhanced natural killer cell activity during liver fibrosis. Its combination of histology, transcriptomics, and mass cytometry supports a broader view of antifibrotic biology, while the toxin-induced model limits direct translation to human MASLD or MASH.
-
Bradykinin: Practical Vascular Research Guide
2026-09-17
This guide explains how to handle Bradykinin (BA5201) for vascular permeability, endothelial vasodilation, smooth muscle, pain, and inflammation studies when no directly matched paper protocol is available. It emphasizes fresh solution preparation, cold and moisture-controlled storage, assay-specific optimization, and clear boundaries against diagnostic or medical use.
-
Carrier-Platin and the ROS Storm in Cancer Cells
2026-09-16
Liu et al. describe carrier-platin, a platinum-based nanotherapeutic that confines ultrasmall platinum nanoparticles within a poly(amino acid) carrier to generate a rapid intracellular ROS burst. The study links this design to cancer-cell death within minutes, including in multidrug-resistant models, while distinguishing the response from conventional DNA-damage-driven apoptosis and ferroptosis.
-
Triamcinolone (B1859): Research Workflow Guide
2026-09-15
Triamcinolone is a synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses identity, DMSO-based preparation, storage, controls, and troubleshooting; the compound is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
TaqI Restriction Endonuclease Protocol
2026-09-15
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA when the TCG A recognition site is present. It is intended for research workflows such as cloning, restriction mapping, and gel-based analysis, not for diagnostic, clinical, or medical use.
-
PP 2 (AG 1879): A Strategic Src Signaling Probe
2026-09-14
PP 2 (AG 1879) is more than a Src-family kinase inhibitor: it is a mechanistic tool for separating kinase-dependent phenotypes from ROS, calcium-channel, and vehicle effects. This article outlines how translational researchers can deploy it rigorously across cancer, immunology, and vascular signaling studies.
-
Verbascoside for PKC/NF-κB Signaling Studies
2026-09-14
Build reproducible PKC/NF-κB pathway experiments with Verbascoside, using dose-response, viability, DNA-binding, and osteoclast differentiation readouts in one workflow. The approach also helps test how NF-κB modulation intersects with the PTX3-TLR4-NF-κB-FGF21 axis reported in glucocorticoid-induced osteonecrosis research.
-
RG7388 MDM2 Antagonist: p53 Activation
2026-09-13
RG7388 is a selective oral MDM2 antagonist that disrupts the p53-MDM2 interaction and supports p53 pathway activation in wild-type p53 cancer models. Product data report nanomolar biochemical and cellular activity, oral tumor-growth inhibition in osteosarcoma xenografts, and combination activity in neuroblastoma models.
-
(-)-Norepinephrine (+)-bitartrate: Lab Guide
2026-09-12
A scenario-driven guide to using (-)-Norepinephrine (+)-bitartrate, SKU C8723, in adrenergic signaling, cell-based assays, and cardiovascular research. It connects receptor pharmacology, fresh-solution handling, assay controls, and literature-based interpretation to improve experimental comparability.
-
AZD1390: Interpreting G4-Driven Checkpoint Stress
2026-09-12
AZD1390 is an ATM kinase inhibitor for testing how replication-associated G-quadruplex stress becomes checkpoint failure and radiosensitivity. This article translates REV1–DHX36 findings into a causal assay strategy that separates G4 persistence, fork dysfunction, and ATM-dependent survival.
-
Clodronate Liposomes for Macrophage Studies
2026-09-11
Clodronate Liposomes provide a practical way to test whether macrophages drive a phenotype in vivo rather than merely correlate with it. This workflow-focused guide connects selective depletion with aging, phagocytosis, tissue-specific immune studies, and better controls.
-
Dronedarone (Multaq) Research Workflows
2026-09-11
Build exposure-aware electrophysiology and metabolism workflows around Dronedarone (Multaq), with practical guidance for solubility, automated patch clamp, and data interpretation. The approach separates clinically relevant exposure from high-concentration screening and uses KCa2 channel findings to sharpen atrial fibrillation treatment research.
-
Morning Endurance Training Improves Mouse Adaptation
2026-09-10
The reference study shows that endurance training during the early active phase produces larger performance gains than training during the late active phase in female mice, even when the early-phase group performs less total work. Its findings separate bulk glycogen content from broader circadian effects on muscle remodeling and provide practical guidance for time-controlled exercise and metabolic studies.
-
DiscoveryProbe Natural Product Library Plus Workflow
2026-09-10
A practical, mechanism-first workflow for turning natural-product diversity into validated enzyme and cell-based screening hits. Learn how to use pre-dissolved compounds, orthogonal readouts, and target-to-phenotype confirmation for antiparasitic discovery and related biomedical programs.
-
Niclosamide B2283: Reliable Cell Assays
2026-09-09
A scenario-based guide to using Niclosamide (SKU B2283) in cell viability, proliferation, apoptosis, and STAT3 research. It connects formulation choices, assay controls, genotype-aware interpretation, and practical product selection to more defensible laboratory results.